top of page
.jpg)
NEW BOOK
LATEST NEWS
Enhance CAR T-Cell Therapy Efficacy and Reduce Toxicity by Using the Microbiome
Past research has long suggested the significant impact of the microbiome on the efficacy of various anticancer treatments, including...
Feb 24
A Life Saved: Woman in Remission for 18 Years After Pioneering CAR T-Cell Therapy for Neuroblastoma
In an inspiring breakthrough for cancer treatment, a woman who underwent an experimental immunotherapy trial as a child has now been in...
Feb 18
Light-Induced Gene Therapy Using Nanoparticles Targets and Destroys Cancer Cells' Mitochondria
A groundbreaking new approach in cancer treatment has emerged, utilizing light to disable the mitochondria, the energy-producing...
Feb 9
GENE TECH TIMES
The Future Has Arrived
Light-Induced Gene Therapy Using Nanoparticles Targets and Destroys Cancer Cells' Mitochondria
A groundbreaking new approach in cancer treatment has emerged, utilizing light to disable the mitochondria, the energy-producing...
Feb 9
Gene Therapy Restores Enzyme Levels to Treat Hypophosphatasia - A More Permanent Treatment
Hypophosphatasia (HPP), or "soft bone disease" is a rare genetic disorder that impacts bone and tooth development, leading to weak bones...
Feb 4
$430 Million Cell and Gene Therapy Center Set to Launch on Long Island, NY
Governor Kathy Hochul has announced New York Biogenesis Park, a $430 million cell and gene therapy hub set to transform the field on Long...
Dec 2, 2024
Regenerating Hearts: How Stem Cell Therapy Could Transform the Treatment of Congenital Heart Diseases
Heart disease is a leading cause of death worldwide, affecting millions at every stage of life, including infants born with congenital...
Dec 1, 2024
FDA Approves BEQVEZ: A Breakthrough One-Time Gene Therapy for Adults with Hemophilia B
Gene therapy is transforming the landscape of treatment options, and the recent FDA approval of BEQVEZ marks a significant milestone for...
May 1, 2024
Two New CRISPR-Based Gene Therapies for Sickle Cell Anemia Approved by the FDA
The FDA recently approved two groundbreaking CRISPR-based gene therapies for curing Sickle Cell Disease (SCD): Casgevy - developed by...
Mar 25, 2024
bottom of page